Clinical trial
A Long-Term, Open-Label, Prospective Phase IV Study to Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
NCT03256838 is registered in ClinicalTrials.gov with Panion & BF Biotech Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-Term, Open-Label, Prospective Phase IV Study to Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
- Lead sponsor
- Panion & BF Biotech Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 12, 2017
- Completion date
- May 31, 2019
- Enrollment
- 202 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage renal disease, hyperphosphatemia, kidney failure, chronic, phosphorus metabolism disorders